Earnings Call Excerpt
Cephalon Inc. (CEPH)
Q4 2005 Earnings Conference Call
February 14th 2006, 5:00 PM.
Executives:
Dr. Frank Baldino Junior, Chief Executive Officer
Kevin Buchi, Chief Financial Officer
Paul Blake, Worldwide Medical and Regulatory Operations
Robert Roche, Worldwide Pharmaceutical Operations
John Osborn, General Council
Chip Merritt, Investor Relations
Robert Grupp, Vice President of Public Affairs
Analysts:
Don Ellis with Thomas Weisel Partners.
Eric Schmidt with S.G. Cowen
Jim Birchenough with Lehman Brothers.
Larry Neibor with Robert W Baird
Corey Davis with J P Morgan.
Marc Goodman with Morgan Stanley.
David Buck, The Buckingham Research.
Greg Gilbert, Merrill Lynch
Adam Greene with First Albany Capital.
Gary Nachman, Leerink Swann company.
David Windley, Jefferies & Company.
Michael Meyers, Trivium Capital Management
Terry Kayson, Merrill Lynch.
Greg Gilbert, Merrill Lynch
Gary Nachman, Leerink Swann company.
Presentation:
Operator
Good day everyone and welcome to Cephalon Fourth Quarter and Yearend 2005 Earnings Announcement. Today's call is being is recorded. At this time for opening remarks, I would like to turn the call over to Mr. Robert Grupp, Vice President of Public Affairs for Cephalon. Please go ahead sir.
Robert Grupp, Vice President of Public Affairs
Thank you, today we will review Cephalon's financial performance for the fourth quarter of 2005, and for the full year. Before we begin, let me remind you the certain statements on this call may be forward-looking, that are subject to the risks and uncertainties associated with Company business. These statements may concern among other things; guidance's as to future revenues and earning, operations, transactions, prospects, intellectual property, litigation, development of pharmaceutical products, clinical trials, and potential expansion of labeled uses of our products.
The company also may discuss certain Non-GAAP financial measures within the meaning of regulation G, during today's call. The information required by regulations G is available on the investor section of our website at www.cephalon.com. Additional information and risk factors affecting the Company's business and financial prospects and factors that would cause Cephalon's actual performance, to vary from our current expectations is available on the Company's current Form 10-K and 10-Q on file with the SEC.
During this call, we will update 2006 guidance. Please note that guidance will remain in effect unless the Company provides subsequent modification or updates. Our earnings press release is available in the Internet at www.cephalon.com investors with further questions, should contact Chip Merritt, at area code 610-738-6376. This conference call is being webcast in the Cephalon homepage and we will be achieved for one week after the call.
- To read the full transcript on Seeking Alpha, click here »
